Literature DB >> 3182993

Identification of a 17-kilodalton Fasciola hepatica immunodiagnostic antigen by the enzyme-linked immunoelectrotransfer blot technique.

G V Hillyer1, M Soler de Galanes.   

Abstract

Sera obtained from human patients, calves, sheep, and rabbits infected with Fasciola hepatica were tested by the Falcon assay screening test enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) techniques with Fasciola hepatica excretory-secretory antigens in order to evaluate their immunodiagnostic potential. The study included sera from 13 patients infected with F. hepatica or a history suggesting fascioliasis, 5 patients infected and treated with bithionol or praziquantel (3 were cured with bithionol), 10 patients infected with Schistosoma mansoni, 6 infected with Trichinella spiralis, and 13 controls and sera from calves, sheep, and rabbits with a primary F. hepatica infection. By FAST-ELISA with F. hepatica excretory-secretory antigens, the serum samples from fascioliasis patients gave the highest absorbance values, and the schistosomiasis patient sera gave intermediate values compared with a normal human serum control. Also by FAST-ELISA, the values for serum from patients with fascioliasis decreased steadily after cure, reaching normal levels 20 to 47 weeks postcure. In contrast, the serum from two patients who had been treated but were not yet cured had high levels of antibodies for up to 3 years of infection. By EITB, the serum samples from humans, rabbits, cattle, and sheep with fascioliasis recognized two antigenic polypeptides of 17 and 63 kilodaltons (kDa) in the form of sharp bands. For humans, this recognition lasted for at least 3 years of infection. Sera from individuals with schistosomiasis mansoni or trichinosis or from normal controls did not recognize the 17-kDa F. hepatica antigenic polypeptide. However, serum from one human with S. mansoni and one with T. spiralis infection has slight bands in the 63-kDa region, suggesting cross-reactivity. Reactivity to the 17-kDa polypeptide was absent in fascioliasis patients at 1 year postcure. Reactivity to the 63-kDa polypeptide was significantly diminished in fascioliasis patients at 1 year postcure. The sera from rabbits with a primary F. hepatica infection also recognized both the 17- and 63-kDa antigenic polypeptides by week 4 of infection. Reactivity to both antigens diminished significantly 6 weeks postcure and disappeared by 8 weeks postcure. The sera from infected cattle and sheep recognized these two antigenic polypeptides by week 8 of infection. These studies suggest that the 17-kDa F. hepatica excretory secretory antigen is an excellent candidate for the immunodiagnosis of acute and chronic fascioliasis. Purification of this antigen and its application to quantitative serologic tests will permit further analysis of its predictive value to evaluate cure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182993      PMCID: PMC266814          DOI: 10.1128/jcm.26.10.2048-2053.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Immunodiagnosis of infection with Schistosoma mansoni: comparison of ELISA, radioimmunoassay, and precipitation tests performed with antigens from eggs.

Authors:  G V Hillyer; E Ruiz Tiben; W B Knight; I Gómez de Rios; R P Pelley
Journal:  Am J Trop Med Hyg       Date:  1979-07       Impact factor: 2.345

2.  A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni eggs.

Authors:  W B Knight; R A Hiatt; B L Cline; L S Ritchie
Journal:  Am J Trop Med Hyg       Date:  1976-11       Impact factor: 2.345

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni.

Authors:  K Hancock; V C Tsang
Journal:  J Immunol Methods       Date:  1986-09-27       Impact factor: 2.303

5.  Use of immunologic techniques to predict success of therapy in human fascioliasis: a case report.

Authors:  G V Hillyer; R H Bermúdez; G Ramírez de Arellano
Journal:  Bol Asoc Med P R       Date:  1984-03

Review 6.  A review of the antigens of Fasciola hepatica.

Authors:  J J Reddington; R W Leid; R B Wescott
Journal:  Vet Parasitol       Date:  1984-06       Impact factor: 2.738

7.  Use of immunologic techniques to detect chemotherapeutic success in infections with Fasciola hepatica. I. Rabbit infections.

Authors:  G V Hillyer; A del Llano de Díaz
Journal:  Am J Trop Med Hyg       Date:  1976-03       Impact factor: 2.345

8.  Immunodiagnosis of human fascioliasis by enzyme-linked immunosorbent assay using excretory-secretory products.

Authors:  A M Espino; B E Duménigo; R Fernández; C M Finlay
Journal:  Am J Trop Med Hyg       Date:  1987-11       Impact factor: 2.345

9.  Identification of functional Fasciola hepatica antigens in experimental infections in rabbits.

Authors:  N Santiago; G V Hillyer; M Garcia-Rosa; M H Morales
Journal:  Am J Trop Med Hyg       Date:  1986-01       Impact factor: 2.345

10.  Characterization of excretory-secretory antigens of Fasciola hepatica.

Authors:  D O Irving; M J Howell
Journal:  Parasitology       Date:  1982-08       Impact factor: 3.234

View more
  11 in total

Review 1.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

Review 2.  The global burden of fasciolosis in domestic animals with an outlook on the contribution of new approaches for diagnosis and control.

Authors:  Muhammad Kasib Khan; Muhammad Sohail Sajid; Hasan Riaz; Nazia Ehsan Ahmad; Lan He; Muhammad Shahzad; Altaf Hussain; Muhammad Nisar Khan; Zafar Iqbal; Junlong Zhao
Journal:  Parasitol Res       Date:  2013-06-01       Impact factor: 2.289

3.  Comparison between in-house indirect ELISA and Dot-ELISA for the diagnosis of Fasciola gigantica in cattle.

Authors:  Jafar Arjmand Yamchi; Nasser Hajipour; Seyyed Meysam Abtahi Froushani; Mojtaba Keighobadi
Journal:  J Parasit Dis       Date:  2015-06-23

4.  Domestically acquired fascioliasis in northern California.

Authors:  Scott A Weisenberg; David E Perlada
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

5.  Humoral immune responses during experimental infection with Fascioloides magna and Fasciola hepatica in goats and comparison of their excretory/secretory products.

Authors:  Adam Novobilský; Martin Kasný; Libor Mikes; Kamil Kovarcík; Bretislav Koudela
Journal:  Parasitol Res       Date:  2007-01-30       Impact factor: 2.289

6.  Diagnotic value of some Fasciola gigantica antigens.

Authors:  Said Shalaby; Mohammad El-Bahy; Ali Hassan; Hatem Shalaby; Neelima Gupta
Journal:  J Parasit Dis       Date:  2013-11-20

7.  Cross-sectional serological survey of human fascioliasis in haiti.

Authors:  P Agnamey; E Fortes-Lopes; C P Raccurt; J Boncy; A Totet
Journal:  J Parasitol Res       Date:  2011-08-25

8.  Helminth-related Eosinophilia in African immigrants, Gran Canaria.

Authors:  Javier Pardo; Cristina Carranza; Antonio Muro; Alfonso Angel-Moreno; Antonio-Manuel Martín; Teresa Martín; Michele Hernández-Cabrera; José-Luis Pérez-Arellano
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

9.  Relevance of eosinophilia and hyper-IgE in immigrant children.

Authors:  Moncef Belhassen-García; Javier Pardo-Lledías; Luis Pérez Del Villar; Antonio Muro; Virginia Velasco-Tirado; Ana Blázquez de Castro; Belen Vicente; M Inmaculada García García; Juan Luis Muñoz Bellido; Miguel Cordero-Sánchez
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

10.  Endomyocardial involvement in asymptomatic sub-Saharan immigrants with helminth-related eosinophilia.

Authors:  Cristina Carranza-Rodríguez; Daniel San-Román-Sánchez; Héctor Marrero-Santiago; Michele Hernández-Cabrera; Carlos Gil-Guillén; Elena Pisos-Álamo; Nieves Jaén-Sánchez; José-Luis Pérez-Arellano
Journal:  PLoS Negl Trop Dis       Date:  2017-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.